Pregnancies during and after trastuzumab and/or lapatinib in patients with human epidermal growth factor receptor 2 –positive early breast cancer: analysis from the NeoALTTO (BIG 1‐06) and ALTTO (BIG 2‐06) trials
Cancer, EarlyView.
Source: Cancer - Category: Cancer & Oncology Authors: Matteo Lambertini,
Samuel Martel,
Christine Campbell,
S ébastien Guillaume,
Florentine S. Hilbers,
Uwe Schuehly,
Larissa Korde,
Hatem A. Azim,
Serena Di Cosimo,
Richard C. Tenglin,
Jens Huober,
José Baselga,
Alvaro Moreno‐Aspitia,
Martine Source Type: research